UK Markets open in 7 hrs 3 mins

AMAG Pharmaceuticals, Inc. (AMAG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.70+0.02 (+0.15%)
At close: 4:00PM EDT

13.70 0.00 (0.00%)
After hours: 4:03PM EDT

Currency in USD

Valuation measures

Market cap (intra-day) 5472.69M
Enterprise value 3632.45M
Trailing P/E N/A
Forward P/E 136.05
PEG ratio (5-yr expected) 10.58
Price/sales (ttm)1.59
Price/book (mrq)1.89
Enterprise value/revenue 32.12
Enterprise value/EBITDA 6-8.55

Trading information

Stock price history

Beta (5Y monthly) 1.03
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 313.80
52-week low 34.41
50-day moving average 311.49
200-day moving average 39.32

Share statistics

Avg vol (3-month) 31.45M
Avg vol (10-day) 31.22M
Shares outstanding 534.5M
Float 23.16M
% held by insiders 11.74%
% held by institutions 1134.32%
Shares short (14 Oct 2020) 47.23M
Short ratio (14 Oct 2020) 42.32
Short % of float (14 Oct 2020) 443.69%
Short % of shares outstanding (14 Oct 2020) 420.95%
Shares short (prior month 14 Sep 2020) 410.16M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:2
Last split date 325 Sep 1991

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020

Profitability

Profit margin -86.95%
Operating margin (ttm)-30.85%

Management effectiveness

Return on assets (ttm)-6.60%
Return on equity (ttm)-69.13%

Income statement

Revenue (ttm)297.7M
Revenue per share (ttm)8.74
Quarterly revenue growth (yoy)-32.20%
Gross profit (ttm)177.7M
EBITDA -74M
Net income avi to common (ttm)-258.84M
Diluted EPS (ttm)-7.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)147.12M
Total cash per share (mrq)4.27
Total debt (mrq)307.89M
Total debt/equity (mrq)123.49
Current ratio (mrq)1.64
Book value per share (mrq)7.23

Cash flow statement

Operating cash flow (ttm)-72.69M
Levered free cash flow (ttm)-133.41M